Patients, doctors and pharma companies set out plans to improve mental health diagnosis

An international group of psychiatrists, patient associations, and pharmaceutical companies has unveiled plans to systematically include objective biological tests in the diagnosis of psychiatric conditions. This Precision Psychiatry Roadmap, which may radically change the practice of psychiatry, is published in the journal Molecular Psychiatry.

👉 Full Story